Tenet Healthcare (THC): Utilization Surge and Cash Flow Upside Drive a Major Valuation Reset—But Can Margins Hold if Coverage Shrinks?

Tenet’s FY25 results highlight a structurally stronger earnings profile driven by disciplined cost management, favorable patient mix, and durable growth across both ambulatory and hospital segments. Consolidated adjusted EBITDA reached $4.57B (+14% YoY) with margins expanding 210bps to 21.4%, materially outperforming initial expectations as operational efficiencies and higher acuity trends supported profitability. USPI continues to anchor Tenet’s growth narrative, generating $2.03B in EBITDA (+12% YoY) with margins above 40% and same-facility revenue growth of 7.5%, reflecting strong procedural volumes and increasing migration toward lower-cost ambulatory settings. Strategic expansion through tuck-in acquisitions and de novo facilities further strengthens this structural tailwind. Meanwhile, hospital segment EBITDA grew 16% to $2.54B as improved labor conditions, lower contract labor usage, and productivity initiatives helped offset industry-wide cost pressures. For FY26, management guides to EBITDA of $4.49B–$4.79B despite a projected $250M headwind tied to the expiration of enhanced ACA premium tax credits, implying continued underlying operating momentum. Strong liquidity, leverage of just 2.25x, and expected FY26 free cash flow of $1.6–$1.83B reinforce capital allocation flexibility through buybacks, M&A, and reinvestment. While utilization trends remain favorable, evolving coverage dynamics could pressure payer mix and uncompensated care levels. If insured patient volumes decline as policy support fades, can Tenet sustain its margin expansion and cash flow trajectory?